Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey.

Autor: Griffin SP; Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA, USA., Signorelli JR; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA., Lasko A; Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA., Andrick BJ; Enterprise Pharmacy, Center for Pharmacy Innovations & Outcomes, Danville, PA, USA., Doan D; Department of Pharmacy, MD Anderson Cancer Center, Houston, TX, USA., Hough S; McKesson, Ann Arbor, MI, USA., Riebandt G; Department of Pharmacy, Clinical Pharmacy Services, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Harnicar S; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Mar; Vol. 30 (2), pp. 332-341. Date of Electronic Publication: 2023 May 16.

Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.

Autor: Lee GW; Geisinger Enterprise Pharmacy, Commonwealth School of Medicine, Danville, PA, USA., Mathur AD; Geisinger Enterprise Pharmacy, Commonwealth School of Medicine, Danville, PA, USA., Andrick BJ; Geisinger Enterprise Pharmacy, Commonwealth School of Medicine, Danville, PA, USA.; Center for Pharmacy Innovations and Outcomes, Commonwealth School of Medicine, Danville, PA, USA., Leese E; Neuroscience Institute, Commonwealth School of Medicine, Danville, PA, USA., Zally D; Geisinger Enterprise Pharmacy, Commonwealth School of Medicine, Danville, PA, USA., Gatson NTN; Neuroscience Institute, Commonwealth School of Medicine, Danville, PA, USA.; Cancer Institute, Commonwealth School of Medicine, Danville, PA, USA.; Geisinger Commonwealth School of Medicine, Scranton, PA, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Dec; Vol. 26 (8), pp. 1937-1941. Date of Electronic Publication: 2020 Sep 17.

Olaratumab: A Novel Platelet-Derived Growth Factor Receptor α-Inhibitor for Advanced Soft Tissue Sarcoma.

Autor: Andrick BJ; 1 Geisinger Medical Center, Danville, PA, USA., Gandhi A; 2 Augusta University Medical Center, Augusta, GA, USA.

Publikováno v: The Annals of pharmacotherapy [Ann Pharmacother] 2017 Dec; Vol. 51 (12), pp. 1090-1098. Date of Electronic Publication: 2017 Aug 04.

Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins.

Autor: Andrick BJ; Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, United States of America., Schwab AI; Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, United States of America., Cauley B; Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, United States of America., O'Donnell LA; Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, United States of America., Meng WS; Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, 15282, United States of America.

Publikováno v: PloS one [PLoS One] 2015 Aug 13; Vol. 10 (8), pp. e0135451. Date of Electronic Publication: 2015 Aug 13 (Print Publication: 2015).